Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.

R Heregger; Florian Huemer; Georg Hutarew; Stefan Hecht; L Cheveresan; Dieter Kotzot; E Schamschula; Gabriel Rinnerthaler; Thomas Melchardt; Lukas Weiss; Richard Greil

doi:10.1016/j.esmoop.2021.100233

Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.

R Heregger, Florian Huemer (Co-Autor/-in), Georg Hutarew (Co-Autor/-in), Stefan Hecht (Co-Autor/-in), L Cheveresan, Dieter Kotzot (Co-Autor/-in), E Schamschula, Gabriel Rinnerthaler (Co-Autor/-in), Thomas Melchardt (Co-Autor/-in), Lukas Weiss (Letztautor/-in), Richard Greil^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

2 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	100233
Fachzeitschrift	ESMO OPEN
Jahrgang	6
Ausgabenummer	4
DOIs	https://doi.org/10.1016/j.esmoop.2021.100233
Publikationsstatus	Veröffentlicht - 2021

Zugriff auf Dokument

10.1016/j.esmoop.2021.100233

Dieses zitieren

Heregger, R., Huemer, F., Hutarew, G., Hecht, S., Cheveresan, L., Kotzot, D., Schamschula, E., Rinnerthaler, G., Melchardt, T., Weiss, L., & Greil, R. (2021). Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature. ESMO OPEN, 6(4), 100233. https://doi.org/10.1016/j.esmoop.2021.100233

Heregger, R ; Huemer, Florian ; Hutarew, Georg et al. / Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature. in: ESMO OPEN. 2021 ; Jahrgang 6, Nr. 4. S. 100233.

@article{be1ae951886e4143b7d9fd518cbfbf1d,

title = "Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.",

keywords = "MALIGNANT PHEOCHROMOCYTOMA, LUNG-CANCER, ALK, PARAGANGLIOMA, NEUROBLASTOMA, CRIZOTINIB, ALECTINIB, CYCLOPHOSPHAMIDE, VINCRISTINE, GENETICS",

author = "R Heregger and Florian Huemer and Georg Hutarew and Stefan Hecht and L Cheveresan and Dieter Kotzot and E Schamschula and Gabriel Rinnerthaler and Thomas Melchardt and Lukas Weiss and Richard Greil",

note = "Heregger; Cheveresan; Huemer; Rinnerthaler; Melchardt; Weiss; Greil: Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria; Hutarew: Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria; Hecht: Institute of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria ",

year = "2021",

doi = "10.1016/j.esmoop.2021.100233",

language = "English",

volume = "6",

pages = "100233",

journal = "ESMO OPEN",

issn = "2059-7029",

publisher = "Elsevier ",

number = "4",

}

Heregger, R, Huemer, F , Hutarew, G , Hecht, S, Cheveresan, L, Kotzot, D, Schamschula, E, Rinnerthaler, G , Melchardt, T , Weiss, L & Greil, R 2021, 'Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.', ESMO OPEN, Jg. 6, Nr. 4, S. 100233. https://doi.org/10.1016/j.esmoop.2021.100233

Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature. / Heregger, R; Huemer, Florian (Co-Autor/-in); Hutarew, Georg (Co-Autor/-in) et al.
in: ESMO OPEN, Jahrgang 6, Nr. 4, 2021, S. 100233.

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

TY - JOUR

T1 - Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.

AU - Heregger, R

AU - Huemer, Florian

AU - Hutarew, Georg

AU - Hecht, Stefan

AU - Cheveresan, L

AU - Kotzot, Dieter

AU - Schamschula, E

AU - Rinnerthaler, Gabriel

AU - Melchardt, Thomas

AU - Weiss, Lukas

AU - Greil, Richard

N1 - Heregger; Cheveresan; Huemer; Rinnerthaler; Melchardt; Weiss; Greil: Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria; Hutarew: Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria; Hecht: Institute of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2021

Y1 - 2021

KW - MALIGNANT PHEOCHROMOCYTOMA

KW - LUNG-CANCER

KW - ALK

KW - PARAGANGLIOMA

KW - NEUROBLASTOMA

KW - CRIZOTINIB

KW - ALECTINIB

KW - CYCLOPHOSPHAMIDE

KW - VINCRISTINE

KW - GENETICS

U2 - 10.1016/j.esmoop.2021.100233

DO - 10.1016/j.esmoop.2021.100233

M3 - Review article

C2 - 34371380

SN - 2059-7029

VL - 6

SP - 100233

JO - ESMO OPEN

JF - ESMO OPEN

IS - 4

ER -

Heregger R, Huemer F , Hutarew G , Hecht S, Cheveresan L, Kotzot D et al. Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature. ESMO OPEN. 2021;6(4):100233. doi: 10.1016/j.esmoop.2021.100233